Navigating the Perilous Road: A Special Panel On Regulatory and Reimbursement Issues

A panel at OneMedForum NY 2011 will explore strategic planning considerations in the process of getting approval and reimbursement.

Read more »

June 23-24 OneMedForum New York

OneMedPlace Trans-Atlantic Conference on June 23rd-24th is a gathering of fast growing, emerging healthcare and life science companies in Europe […]

Read more »

Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections

The antibiotic market is expected to reach $45 billion by 2012 driven by the deficiencies of currently available antibiotics.

Read more »

Small Bone Innovations Addresses Unmet Needs in Joint Replacement

Orthopedic companies have focused on developing devices for large bone trauma, leaving the small bone and joint field lacking.

Read more »

Hepregen Awarded $500,000 Massachusetts Life Sciences Center Grant

Hepregen, a leading provider of bioengineered solutions that increase success in drug development, was awarded a $500,000 grant as part of the Small Business Matching Grants program

Read more »

GlySure’s Technology May Break Barrier For Tight Control And Automated Glucose Monitoring

GlySure’s technology enables a healthcare facility to implement tight glycemic control and intensive insulin therapy.

Read more »

Advanced Cardiac Therapeutics Studies Innovative Catheter System To Treat Arrythmias

ACT recently announced that the first patients have been enrolled in a CE Mark clinical trial of the safety and performance of the company’s TEMPASURE cardiac ablation catheter.

Read more »

Rubigo Therapeutics Develops Early Assessment and Treatment for Skin Cancer

The fear of having cancer is not unfounded as the incidence of skin cancer is increasing at an alarming rate due in large part by UV exposure or excessive sun burn.

Read more »

Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide

In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.

Read more »

Threshold Pharmaceuticals Selectively Targets Tumor Cells in Cancer Therapeutics

Threshold Pharmaceuticals takes advantage of the differences in metabolic activity between cancerous and normal, healthy biological tissue.

Read more »